Dr. Alka Chaubey, chief medical officer at Bionano, Dr. Nikhil Sahajpal, Greenwood Genetic Center,Dr. Rashmi Kanagal-Shamanna,MD Anderson Cancer Center, and Dr. Adam Smith,University Health Network will hosta sponsored vendor presentation onstudies that include multiple types of hematological malignancies, and highlight the benefits of combining optical genome mapping (OGM) with next generation sequencing (NGS) to maximize actionable results
A scientific presentation featuringDr. Chaubey, Dr. Kanagal-Shamanna, Dr. Ravindra Kolhe, Augusta University, and Dr. Christopher Lum, Queens Medical Center will covermethodologies forhomologous recombination deficiency (HRD) assessment, including NGS, microarray and OGM, as well as bioinformatics approaches for analysis of data across solid tumors and hematological malignancies
A plenary session will feature Dr. Smith delivering a presentation on the implementation of long-read sequencing (LRS) and OGM for cytogenetic research, and will be immediately followed by a panel discussion on the use of new tools, including OGM, in next generation cytogenomics, featuring Dr. Smith, Dr. Eric Duncavage, Washington University School of Medicine, Dr. Yassmine Akkari,Nationwide Children’s Hospital andDr. Robert Hasserjian, Massachusetts General Hospital
